BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7999409)

  • 1. Serum levels of tumour necrosis factor-alpha in patients with B-cell chronic lymphocytic leukaemia.
    Adami F; Guarini A; Pini M; Siviero F; Sancetta R; Massaia M; Trentin L; Foà R; Semenzato G
    Eur J Cancer; 1994; 30A(9):1259-63. PubMed ID: 7999409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia.
    Ferrajoli A; Keating MJ; Manshouri T; Giles FJ; Dey A; Estrov Z; Koller CA; Kurzrock R; Thomas DA; Faderl S; Lerner S; O'Brien S; Albitar M
    Blood; 2002 Aug; 100(4):1215-9. PubMed ID: 12149200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia.
    Aref S; Salama O; Shamaa S; El-Refaie M; Mourkos H
    Hematology; 2007 Aug; 12(4):319-24. PubMed ID: 17654059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of tumor necrosis factor-alpha and erythropoietin serum levels in B-cell chronic lymphocytic leukemia patients with anemia.
    Capalbo S; Battista C; Delia M; Ciancio A; De Santis G; Dargenio M; Diomede D; Liso V
    Acta Haematol; 2002; 108(2):84-9. PubMed ID: 12187026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia.
    Reittie JE; Yong KL; Panayiotidis P; Hoffbrand AV
    Leuk Lymphoma; 1996 Jun; 22(1-2):83-90, follow. 186, color plate VI. PubMed ID: 8724532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia.
    Kamper EF; Papaphilis AD; Angelopoulou MK; Kopeikina LT; Siakantaris MP; Pangalis GA; Stavridis JC
    Clin Biochem; 1999 Nov; 32(8):639-45. PubMed ID: 10638947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia.
    Molica S; Vitelli G; Cutrona G; Todoerti K; Mirabelli R; Digiesi G; Giannarelli D; Sperduti I; Molica M; Gentile M; Morabito F; Neri A; Ferrarini M
    Int J Hematol; 2008 Nov; 88(4):374-380. PubMed ID: 18818986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
    Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of S-phase white blood cell count in B-cell chronic lymphocytic leukemia.
    Orfao A; Ciudad J; González M; San Miguel JF; García AR; López-Berges MC; Ramos F; Del Cañizo MC; Ríos A; Sanz M
    Leukemia; 1992 Jan; 6(1):47-51. PubMed ID: 1736013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-2-microglobulin is a reliable tumor marker in chronic lymphocytic leukemia.
    Di Giovanni S; Valentini G; Carducci P; Giallonardo P
    Acta Haematol; 1989; 81(4):181-5. PubMed ID: 2502891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies for early-stage chronic lymphocytic leukemia: can interferon-inducible MxA protein and tumor necrosis factor play a role as predictive markers for response to interferon therapy?
    Bezares F; Kohan S; Sacerdote de Lustig E; Farías E; Murro H; Horisberger MA
    J Interferon Cytokine Res; 1996 Jul; 16(7):501-5. PubMed ID: 8836914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
    Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
    Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
    Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
    Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy.
    Jewell AP; Worman CP; Giles FJ; Goldstone AH
    Leuk Lymphoma; 1997 Jan; 24(3-4):327-33. PubMed ID: 9156662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased production of TNF and IL-6 in whole blood of CLL patients.
    Dahlke E; Schlag R; Langenmayer I; Frankenberger M; Käfferlein E; Subkowski T; Emmerich B; Ziegler-Heitbrock HW
    Am J Hematol; 1995 May; 49(1):76-82. PubMed ID: 7741143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in stage AO B-cell chronic lymphocytic leukaemia.
    Oscier DG; Stevens J; Hamblin TJ; Pickering RM; Fitchett M
    Br J Haematol; 1990 Nov; 76(3):348-51. PubMed ID: 2261344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished production of interleukin-6 in chronic lymphocytic leukaemia (B-CLL) cells from patients at advanced stages of disease. Tampere CLL Group.
    Hulkkonen J; Vilpo J; Vilpo L; Hurme M
    Br J Haematol; 1998 Mar; 100(3):478-83. PubMed ID: 9504629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of surface dipeptidylpeptidase IV (CD26) expression in B-cell chronic lymphocytic leukemia.
    Matuszak M; Lewandowski K; Czyż A; Kiernicka-Parulska J; Przybyłowicz-Chalecka A; Jarmuż-Szymczak M; Lewandowska M; Komarnicki M
    Leuk Res; 2016 Aug; 47():166-71. PubMed ID: 27376546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.